Sales in the world gamma/scintillation cameras market, driven by endeavors towards the development of newer radiopharmaceuticals, sophistication of product technologies and the creation of integrated products, will exceed $913 million by 2010, according to Global Industry Analysts (GIA), a market research firm.
PET is the success story of nuclear medicine, flooding the markets with PET or PET enabled/co-incidence-equipped scintillation cameras. Increasing popularity of PET procedures is expected to hurt sales of conventional gamma/scintillation cameras in the coming years, GIA reported.
The United States is the largest market for gamma/scintillation cameras and accessories, according to the firm.
In 2007, the United States accounted for roughly 57 percent of the global gamma/scintillation cameras and accessories market. Latin America and Asia-Pacific represent the fastest growing markets over the period 2000-2010 with compound annual growth rates (CAGRs) between 3 and 3.5 percent for the period 2000-2010. Europe represents the second largest market, next to the United States. Among the segments analyzed, the Nuclear Medicine Patient Tables market in the region is projected to reach $10.6 million by the year 2010, GIA said.
Industry-wide, the firm said the urge to curtail inconveniences and to enhance precision performance levels has driven manufacturers to devise fusion imaging technologies and multi-purpose systems capable of faster and reliable diagnostic performances, causing minimal discomfort to patients.
Simplification, enhanced system integration and advanced software setups offering more control over the results, are making headway into the design of the gamma/scintillation imaging systems, according to the firm.
Globally, gamma camera sales are projected to trim down to $435 million by 2010, due to reimbursement issues and competition from other imaging modalities, reported GIA.